ロード中...
Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs
OBJECTIVE: To comprehensively assess the pharmacogenomic evidence of routinely-used drugs for clinical utility. METHODS: From January 2, 2011 to May 31, 2013, we assessed 71 drugs by identifying all drug/genetic variant combinations with published clinical pharmacogenomic evidence. Literature suppor...
保存先:
| 出版年: | Mayo Clin Proc |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4475352/ https://ncbi.nlm.nih.gov/pubmed/26046407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2015.03.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|